“Evaluation of the pharmacotherapeutic follow-up effectiveness in patients with dyslipidemia in the secondary health care in the Brazilian Unified Health System (SUS)” (2022) Brazilian Journal of Pharmaceutical Sciences, 58. doi:10.1590/s2175-97902022e20400.